Holen Sie sich die Stockscreener-App
6.35
0.63%
0.04
Handel nachbörslich:
6.47
0.12
+1.89%
Schlusskurs vom Vortag:
$6.31
Offen:
$6.22
24-Stunden-Volumen:
242.45K
Relative Volume:
0.69
Marktkapitalisierung:
$358.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-72.89M
KGV:
-2.624
EPS:
-2.42
Netto-Cashflow:
$-68.47M
1W Leistung:
-6.07%
1M Leistung:
+1.44%
6M Leistung:
-6.75%
1J Leistung:
-46.77%
1-Tages-Spanne:
$6.12
$6.45
1-Wochen-Bereich:
$6.12
$7.14
52-Wochen-Spanne:
$3.555
$12.92
Astria Therapeutics Inc Stock (ATXS) Company Profile
Firmenname
Astria Therapeutics Inc
Sektor
Branche
Telefon
617-349-1971
Adresse
22 BOSTON WHARF ROAD, BOSTON
Vergleichen Sie ATXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATXS
Astria Therapeutics Inc
|
6.35 | 382.63M | 0 | -72.89M | -68.47M | -2.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.46 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.16 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
467.55 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
663.73 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.97 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-31 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-07-29 | Eingeleitet | TD Cowen | Buy |
| 2023-03-28 | Eingeleitet | Evercore ISI | Outperform |
Astria Therapeutics Inc Aktie (ATXS) Neueste Nachrichten
Astria Therapeutics Inc. stock volume spike explained2025 Buyback Activity & Entry Point Confirmation Alerts - Newser
Signal strength of Astria Therapeutics Inc. stock in tech scannersEarnings Miss & Consistent Growth Stock Picks - Newser
Is Astria Therapeutics Inc. stock ready for a breakoutTrade Risk Assessment & Capital Efficiency Focused Ideas - Newser
Forecasting Astria Therapeutics Inc. price range with options data2025 Trading Volume Trends & Long-Term Growth Stock Strategies - Newser
Published on: 2025-08-19 23:26:47 - Newser
Will Astria Therapeutics Inc. continue its uptrendQuarterly Risk Review & Weekly Top Gainers Alerts - Newser
Why Astria Therapeutics Inc. stock attracts strong analyst attentionQuarterly Performance Summary & Weekly Watchlist for Consistent Profits - Newser
Can trapped investors hope for a rebound in Astria Therapeutics Inc.Entry Point & Technical Pattern Alert System - Newser
Can Astria Therapeutics Inc. hit a new high this month2025 Momentum Check & Risk Adjusted Swing Trade Ideas - Newser
Will Astria Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsShare Buyback & Capital Protection Trading Alerts - Newser
Technical signs of recovery in Astria Therapeutics Inc.Quarterly Portfolio Report & Stepwise Trade Signal Implementation - Newser
Long term hold vs stop loss in Astria Therapeutics Inc.2025 Macro Impact & Free Safe Entry Trade Signal Reports - Newser
Healthcare Sector Analysts Offer Insights on Revolution Medicines, Astria Therapeutics, and AbbVie - AInvest
Is This the Dip to Buy in Astria Therapeutics Inc.Market Risk Analysis & Stepwise Trade Execution Plans - newsimpact.co.kr
Astria Therapeutics Reports Q2 2025 Earnings Loss, Market Reacts with Mixed Short-Term Volatility - AInvest
Is Astria Therapeutics Inc. showing signs of accumulationJuly 2025 Price Swings & Verified Entry Point Signals - Newser
Astria Therapeutics Inc. stock momentum explainedQuarterly Risk Review & High Win Rate Trade Alerts - Newser
Astria Therapeutics Q2 Earnings Miss: Mixed Short-Term Market Impact and Recovery Signals - AInvest
Applying sector rotation models to Astria Therapeutics Inc.2025 Investor Takeaways & Expert Approved Trade Ideas - Newser
what makes astria therapeutics inc. stock price move sharplyFree Sector Rotation Based Trading Opportunities - Newser
FY2025 EPS Estimates for ATXS Increased by Cantor Fitzgerald - Defense World
Financial Analysis: Arcellx (NASDAQ:ACLX) and Astria Therapeutics (NASDAQ:ATXS) - Defense World
How high can Astria Therapeutics Inc. stock goMarket Activity Summary & Free High Return Stock Watch Alerts - Newser
Price action breakdown for Astria Therapeutics Inc.July 2025 Snapshot & Advanced Swing Trade Entry Plans - Newser
What earnings revisions data tells us about Astria Therapeutics Inc.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - Newser
Published on: 2025-08-16 17:45:58 - metal.it
Is Astria Therapeutics Inc. a candidate for recovery playJuly 2025 Big Picture & Smart Investment Allocation Tips - Newser
Does Astria Therapeutics (ATXS) Have the Potential to Rally 333.88% as Wall Street Analysts Expect? - msn.com
Q3 EPS Forecast for Astria Therapeutics Raised by Analyst - Defense World
Q3 Earnings Forecast for ATXS Issued By Lifesci Capital - Defense World
Equities Analysts Set Expectations for ATXS Q3 Earnings - Defense World
JMP Securities Increases Astria Therapeutics (NASDAQ:ATXS) Price Target to $26.00 - Defense World
Astria Therapeutics Reports Increased Losses Amid R&D Expansion - TipRanks
Finanzdaten der Astria Therapeutics Inc-Aktie (ATXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.55%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):